Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05148767 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

UGT1A1-Based Irinotecan Therapy for Locally Advanced Rectal Cancer

StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated December 8, 2021 (before its estimated June 1, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
To explore whether the application of irinotecan under the guidance of UGT1A1 gene in neoadjuvant chemotherapy and radiotherapy for locally advanced rectal cancer could improve the clinical efficacy in the real world.
Trial Details
NCT Number NCT05148767
Lead Sponsor Zhejiang Cancer Hospital
Conditions
(from sponsor)		 Rectal Cancer Stage III
Related terms Rectal Neoplasms
Enrollment 606 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov